Canaccord keeps Hold rating for InMode stock with USD 15 target

Published on 10/15/2026 at 13:41 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

InMode projects Q3 revenue of USD 91.8 million to USD 92.0 million. InMode stock costs EUR 12.85 on October 15, 2026 at Lang & Schwarz.

Analyst view and earnings setup

Canaccord Genuity reiterated a Hold rating and set a USD 15.00 target on October 14, 2026.
InMode expects third-quarter 2026 revenue of USD 91.80 million to USD 92.00 million.
InMode stock traded at EUR 12.85 at 1:34 p.m. CEST at Lang & Schwarz on October 15, 2026.

INMD, IL0011595993, Illustration mit AI erstellt.

InMode Ltd. (IL0011595993) drew a Hold rating and a USD 15.00 price target from Canaccord Genuity analyst Caitlin Roberts on October 14, 2026, according to Markets Insider. The company also outlined preliminary third-quarter revenue of USD 91.80 million to USD 92.00 million for the period ending September 30, 2026.

Guidance points to November results

InMode expects to publish its third-quarter 2026 results before the Nasdaq market opens on November 11, 2026. The date and revenue range came from the company's October 13 release carried by PR Newswire.

The same release reiterated full-year 2026 revenue guidance of USD 365.00 million to USD 375.00 million. That range brackets the USD 370.27 million consensus estimate cited by TokenPost, giving investors a concrete benchmark for the November report.

What changed over recent months

InMode's recent chronology shows a stable revenue base but lower quarterly profit. On August 5, 2026, the company reported second-quarter revenue of USD 95.59 million and net profit of USD 17.06 million, according to Markets Insider. On October 13, 2026, management projected third-quarter revenue of USD 91.80 million to USD 92.00 million. On October 14, 2026, Canaccord Genuity kept its Hold rating and set a USD 15.00 target.

The next substantiated event is the third-quarter results release on November 11, 2026. The revenue range and the full-year guidance place the upcoming report at the center of the stock's near-term valuation discussion.

Stock price and company profile

InMode designs and sells minimally invasive and non-invasive medical aesthetic devices, with radio frequency technology used across plastic surgery, gynecology, dermatology, otolaryngology and ophthalmology. MarketWatch identifies the primary listing as Nasdaq and reported a USD 823.20 million market capitalization, a USD 12.72 to USD 16.67 52-week range and a USD 14.28 Nasdaq quote on October 14, 2026.

InMode stock traded at EUR 12.85 at Lang & Schwarz on October 15, 2026 at 1:34 p.m. CEST. The further course of trading is shown by the continuously updated real-time quote of InMode stock.